Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-5-3
pubmed:abstractText
The objective of this study was to evaluate the cost-effectiveness of insulin glargine compared with NPH insulin in patients with type 2 diabetes and in whom OAD (oral anti-diabetics) had failed in Switzerland.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0946-1965
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
203-20
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17474539-Aged, pubmed-meshheading:17474539-Computer Simulation, pubmed-meshheading:17474539-Cost-Benefit Analysis, pubmed-meshheading:17474539-Diabetes Mellitus, Type 2, pubmed-meshheading:17474539-Epidemiologic Methods, pubmed-meshheading:17474539-Female, pubmed-meshheading:17474539-Health Care Costs, pubmed-meshheading:17474539-Hemoglobin A, Glycosylated, pubmed-meshheading:17474539-Humans, pubmed-meshheading:17474539-Hypoglycemic Agents, pubmed-meshheading:17474539-Insulin, pubmed-meshheading:17474539-Insulin, Isophane, pubmed-meshheading:17474539-Insulin, Long-Acting, pubmed-meshheading:17474539-Male, pubmed-meshheading:17474539-Middle Aged, pubmed-meshheading:17474539-Quality of Life, pubmed-meshheading:17474539-Quality-Adjusted Life Years, pubmed-meshheading:17474539-Switzerland
pubmed:year
2007
pubmed:articleTitle
Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.
pubmed:affiliation
Division of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St. Gallen, Switzerland. Michael.Braendle@kssg.ch
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Evaluation Studies